Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells-Reference-Cited by-同舟云学术

Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells

Published:2004-02-21 Issue:7 Volume:47 Page:1595-1598
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Carraro Fabio¹,Pucci Annalisa¹,Naldini Antonella¹,Schenone Silvia¹,Bruno Olga¹,Ranise Angelo¹,Bondavalli Francesco¹,Brullo Chiara¹,Fossa Paola¹,Menozzi Giulia¹,Mosti Luisa¹,Manetti Fabrizio¹,Botta Maurizio¹

Affiliation:

1. Dipartimento di Fisiologia, Unità di Fisiologia Cellulare e Molecolare, Università degli Studi di Siena, Via Aldo Moro, I-53100 Siena, Italy, Dipartimento di Scienze Farmaceutiche, Università degli Studi di Genova, Viale Benedetto XV, I-16132, Genova, Italy, and Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via Aldo Moro, I-53100 Siena, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm034257u

Reference20 articles.

1. The Descriptive Epidemiology of Second Primary Breast Cancer

2. Oxygen-Mediated Regulation of Gelatinase and Tissue Inhibitor of Metalloproteinases-1 Expression by Invasive Cells

3. A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold for Anti-Cancer Drug Discovery;Current Topics in Medicinal Chemistry;2022-02

2. Three-Dimensional Interactions Analysis of the Anticancer Target c-Src Kinase with Its Inhibitors;Cancers;2020-08-18

3. Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment;Bioorganic & Medicinal Chemistry Letters;2018-11

4. Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity;Molecular Cancer;2018-02-19

5. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies;European Journal of Medicinal Chemistry;2017-10